The "Lila Manfield Sapinsley Compassionate Care Act" introduces a new chapter in Title 23 of the General Laws, focusing on health and safety, specifically addressing the prescription of medication to hasten the death of terminally ill patients. The bill establishes key definitions such as "bona fide physician-patient relationship," "capable," and "terminal condition," and outlines the requirements for physicians to follow in order to avoid civil or criminal liability. These requirements include confirming the patient's terminal condition, ensuring the patient is capable of making informed decisions, and providing comprehensive information about treatment options and risks. Physicians must document the patient's requests for medication, which must be made both orally and in writing, and witnessed by individuals who are not "interested persons." Additionally, a second opinion is required to confirm the diagnosis and the patient's decision-making capacity.

The bill also includes important provisions that protect healthcare providers, allowing them to opt out of participating in the provision of lethal medication without facing penalties. It clarifies that life insurance benefits cannot be denied based on actions taken in accordance with the bill and emphasizes that it does not authorize euthanasia or assisted suicide. Key insertions in the bill include the requirement for a 48-hour waiting period after the patient's last oral request before a prescription can be written, as well as the stipulation that a patient self-administering a lethal dose will not be considered exposed to grave physical harm. Overall, the act aims to provide a compassionate and legally sound framework for end-of-life care while ensuring patient autonomy and safety.